Tandem Diabetes Care®, Inc. (NASDAQ:TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced commencement of shipments for its next-generation t:slim X2™ Insulin Pump. The t:slim X2 Pump boasts an advanced Bluetooth radio and is optimized for use with Tandem’s recently cleared Tandem Device Updater, designed to update software and add new features from a personal computer as they are approved by the U.S. Food and Drug Administration (FDA).1
The t:slim X2 Pump is the newest addition to the Company’s family of innovative insulin pumps. All Tandem pumps feature a high-contrast color touchscreen with a streamlined, user-friendly interface. This provides people rapid access to frequently used features, while making these features simple to learn and simple to use.2 Each Tandem product utilizes modern technology, such as a built-in rechargeable battery and micro-USB port for convenient charging and fast data transfers.
Notable features of the t:slim X2 Pump include:
- Up to 38% smaller than other insulin pumps
- 300-unit capacity
- Rechargeable battery, which saves hundreds of dollars in out of pocket costs
- Durable aluminum housing
- Watertight (IPX7) construction, tested to a depth of three feet for 30 minutes
- Advanced Bluetooth radio, capable of communicating with compatible devices and future technologies
- Optimized for use with the Tandem Device Updater for remote software and feature updates from a personal computer
The t:slim X2 Pump will replace Tandem’s first-generation t:slim® Insulin Pump. The Company will continue to support current t:slim Pumps, in addition to the t:slim G4™ and t:flex® Insulin Pumps. The t:slim X2 Pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin, for individuals 12 years of age and greater.
About the Tandem Device Updater
The Tandem Device Updater, cleared by the FDA in July 2016, is a tool for the remote update of Tandem insulin pump software from a personal computer. The first use of the Tandem Device Updater is to provide t:slim® Insulin Pumps purchased before April 2015 with a free update to the latest software features. This updated software began shipping on new t:slim Pumps as of April 2015 and includes a variety of product enhancements for convenience and flexibility. Software updates and new features for Tandem pumps are being developed for implementation through the Tandem Device Updater as they are approved for commercial distribution.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim X2™ Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements, and the t:slim G4™ Insulin Pump, the first continuous glucose monitoring-enabled pump with touch-screen simplicity. Tandem is based in San Diego, California.